
Annual report 2025
added 02-23-2026
Hims & Hers Health Revenue 2011-2026 | HIMS
Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.
Traditionally defined as follows:Revenue = Price * Quantity of productsRevenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]
This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.
Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.
Annual Revenue Hims & Hers Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.35 B | 1.48 B | 872 M | 527 M | 272 M | 149 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.35 B | 149 M | 941 M |
Quarterly Revenue Hims & Hers Health
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 599 M | 545 M | 586 M | 402 M | 316 M | 278 M | 227 M | 208 M | 191 M | - | 145 M | 114 M | 101 M | - | 74.2 M | 60.7 M | 52.3 M | - | 41.3 M | 35.9 M | 30.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 599 M | 30.1 M | 222 M |
References
- Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).
Revenue of other stocks in the Household products industry
| Issuer | Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Natura &Co Holding S.A.
NTCO
|
26.7 B | - | - | $ 9.02 B | - | |
|
Colgate-Palmolive Company
CL
|
20.4 B | $ 90.3 | 1.64 % | $ 73 B | ||
|
The Clorox Company
CLX
|
7.1 B | $ 112.09 | 1.28 % | $ 13.8 B | ||
|
Coty
COTY
|
5.89 B | $ 2.21 | -0.45 % | $ 1.92 B | ||
|
Helen of Troy Limited
HELE
|
1.91 B | $ 15.78 | -4.19 % | $ 363 M | ||
|
Edgewell Personal Care Company
EPC
|
2.25 B | $ 20.24 | 2.43 % | $ 1.01 B | ||
|
Inter Parfums
IPAR
|
1.49 B | $ 91.2 | 0.56 % | $ 2.93 B | ||
|
e.l.f. Beauty
ELF
|
321 M | $ 73.62 | 0.29 % | $ 4.03 B | ||
|
Kimberly-Clark Corporation
KMB
|
4.08 B | $ 100.26 | 1.44 % | $ 33.3 B | ||
|
The Estée Lauder Companies
EL
|
14.3 B | $ 88.76 | 1.0 % | $ 32 B | ||
|
LifeVantage Corporation
LFVN
|
229 M | $ 5.15 | -0.77 % | $ 63.1 M | ||
|
Church & Dwight Co.
CHD
|
6.2 B | $ 98.22 | 0.48 % | $ 23.8 B | ||
|
Nature's Sunshine Products
NATR
|
480 M | $ 24.33 | -0.65 % | $ 438 M | ||
|
Nu Skin Enterprises
NUS
|
1.73 B | $ 7.21 | 0.56 % | $ 355 M | ||
|
Newell Brands
NWL
|
7.2 B | $ 3.9 | -3.47 % | $ 1.63 B | ||
|
The Procter & Gamble Company
PG
|
84.3 B | $ 152.12 | 0.98 % | $ 357 B | ||
|
Unilever PLC
UL
|
50.5 B | $ 65.43 | 2.15 % | $ 132 B | ||
|
Mannatech, Incorporated
MTEX
|
132 M | $ 6.6 | - | $ 12.3 M | ||
|
Revlon
REV
|
2.08 B | - | -4.41 % | $ 212 M | ||
|
Spectrum Brands Holdings
SPB
|
2.81 B | $ 74.2 | 0.65 % | $ 1.91 B | ||
|
United-Guardian
UG
|
10.9 M | $ 6.54 | -2.1 % | $ 30 M | ||
|
USANA Health Sciences
USNA
|
925 M | $ 17.54 | 1.15 % | $ 338 M | ||
|
Acme United Corporation
ACU
|
197 M | $ 46.0 | 5.02 % | $ 174 M | ||
|
Dogness (International) Corporation
DOGZ
|
27.1 M | $ 1.52 | - | $ 51.2 M |